MCTMedic serves as a Food for Special Medical Purposes / Medical Food for patients unable to sufficiently digest or absorb conventional fats and for the dietary management of patients suffering from drug-resistant epilepsy, also known as refractory epilepsy. Besides these areas of use, there are also less common conditions where the dietary management with MCTs is beneficial.

MCTMedic is derived from modified coconut and palm kernel oil in order to minimize the presence of long-chain fatty acids (<1%). Even though Lauric acid (C12:0) is classified as a medium-chain fatty acid, we were able to minimize the level to <2.5%.  For optimal efficacy, a chain length below 12 carbon is preferred. Our product contains a minimum of 95% of a mixture of caprylic (C8:0) and capric (C10:0) fatty acids.

It has very low viscosity and excellent oxidative stability with essentially no odor or flavor. The molecules are slightly polar which makes it dissolvable in a variety of substances. This product contains no trans fatty acids.

MCTMedic is for patients unable to sufficiently digest or absorb conventional fats and for the dietary management of patients suffering from drug-resistant epilepsy, also known as refractory epilepsy. Besides these areas of use, there are also less common conditions where dietary management with MCTs is beneficial.

Conditions linked to a disturbance in the use of LCTs (partial list)::
- Pancreatic insufficiency (Chronic/Acute Pancreatitis, Cystic fibrosis)
- Short Bowel Syndrome
- Chyle leaks
- Liver conditions

MCT use as a source for ketones formation (partial list):
‍- Refractory epilepsy
- Neurodegenerative disorders

Other applications (partial list):
‍- Severe malnutrition